Very few data regarding the use of infliximab in children with very early-onset inflammatory bowel disease (VEO-IBD) have been reported. We aimed to assess the efficacy and the safety of infliximab in children with VEO-IBD compared with older children.

Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study / Bramuzzo M, A.S.. - In: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. - ISSN 2050-6414. - ELETTRONICO. - (2019), pp. 759-766.

Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study

Lionetti P;Paci M;
2019

Abstract

Very few data regarding the use of infliximab in children with very early-onset inflammatory bowel disease (VEO-IBD) have been reported. We aimed to assess the efficacy and the safety of infliximab in children with VEO-IBD compared with older children.
2019
759
766
Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Marteloss...espandi
1a - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1218444
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 44
  • ???jsp.display-item.citation.isi??? ND
social impact